10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $284,924 | -3.4% | 7,819 | -24.6% | 0.08% | -9.4% |
| Q3 2022 | $295,000 | -37.1% | 10,371 | 0.0% | 0.08% | -46.2% |
| Q2 2022 | $469,000 | -3.3% | 10,371 | +62.6% | 0.16% | +1.9% |
| Q1 2022 | $485,000 | +27.6% | 6,380 | +150.0% | 0.16% | +10.7% |
| Q4 2021 | $380,000 | -56.7% | 2,552 | -47.4% | 0.14% | -67.9% |
| Q1 2021 | $877,000 | +147.7% | 4,848 | +70.8% | 0.44% | -23.2% |
| Q3 2020 | $354,000 | – | 2,839 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |